azacitidine
Showing 1 - 25 of 315
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Lenalidomide
- Azacitidine
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)
Recruiting
- Peripheral T Cell Lymphoma
- Epigenetic Repression
- Chidamide
- Azacitidine
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 14, 2023
Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2023
MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
- BC3402
- Azacitidine
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023
Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
- (no location specified)
Mar 15, 2023
Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)
Not yet recruiting
- Leukemia, Juvenile Myelomonocytic
- +4 more
- Trametinib
- +3 more
- (no location specified)
May 4, 2023
High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)
Recruiting
- High Grade Myelodysplastic Syndromes
- Omacetaxine
- Azacitidine
-
Aurora, ColoradoUniverstiy of Colorado Denver
Nov 17, 2022
DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)
Recruiting
- Diffuse Large B-Cell Lymphoma
- Chidamide
- +3 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM.D. Anderson Cancer Center
Apr 17, 2023
Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Ivosidenib Oral Tablet
- Azacitidine
-
Vienna, Austria
- +3 more
Jun 8, 2023
Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)
Active, not recruiting
- Pancreas Cancer
- Pembrolizumab
- Azacitidine
-
New York, New YorkColumbia University Irving Medical Center
Nov 29, 2022
AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)
Not yet recruiting
- AML, Adult
- azacitidine
- +2 more
-
Amersfoort, Netherlands
- +17 more
Aug 23, 2023
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- LP-108
- Azacitidine
- (no location specified)
Nov 29, 2022
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston
Active, not recruiting
- Chronic Myelomonocytic Leukemia-0
- +5 more
- Azacitidine
- Seclidemstat
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2023
Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life
Recruiting
- Secondary Myelodysplastic Syndrome
- Therapy-Related Myelodysplastic Syndrome
- Azacitidine
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2022
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
- Azacitidine
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Homoharringtonine
- Azacitidine
-
NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022
Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
-
Aurora, ColoradoUniverstiy of Colorado Hospital
Aug 22, 2022
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
- Azacitidine
- Pembrolizumab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 31, 2022
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- BLU-263
- Azacitidine
- (no location specified)
Nov 2, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)
Not yet recruiting
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- AMG 176
- Azacitidine
- (no location specified)
Jul 29, 2022